Skip to main content

National Health Expenditures Set to Increase Through 2031

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, June 16, 2023 -- Over the course of 2022 to 2031, national health expenditures are projected to increase 5.4 percent on average per year, and account for about 20 percent of the gross domestic product (GDP), according to a study published online June 14 in Health Affairs.

Sean P. Keehan, from the Centers for Medicare & Medicaid Services in Baltimore, and colleagues projected nation health spending for 2022 to 2031 in the United States.

The authors note that health spending is expected to increase 5.4 percent per year over the course of 2022 to 2031, outpacing projected average growth in nominal GDP of 4.6 percent per year, and resulting in a health spending share of 19.6 percent of GDP by 2031. In 2022, the insured share of the population is projected to reach a history high of 92.3 percent, which will remain above 92 percent through 2023 before decreasing to 90.5 percent by 2031, partly as a result of the expiration of pandemic-related legislation. Beginning in 2024, the prescription drug provisions of the Inflation Reduction Act of 2022 are expected to reduce out-of-pocket spending for Medicare Part D enrollees, which will result in savings to Medicare starting in 2031.

"Altogether, and consistent with its past trend, health spending over the course of the next 10 years is expected to grow more rapidly, on average, than the overall economy, and by 2031, it will account for roughly $1 out of every $5 spent in the United States," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Mortality in Rheumatic Heart Disease Is High

FRIDAY, June 7, 2024 -- Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June...

Higher County-Level Prostate Cancer Screening Tied to Better Outcomes

FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...

Metabolic Impact on Offspring Similar for Frozen, Fresh Embryo Transfer

FRIDAY, June 7, 2024 -- For glucose and lipid profiles during early childhood, the impact of frozen embryo transfer (FET) is comparable to that of fresh embryo transfer, according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.